 Inhibition diabetes-associated complications nucleophilic compounds Mono- diaminoguanidine ambient glucose-induced glycosylated end product formation albumin collagen albumin covalent binding vitro Diaminoguanidine inhibitor monoaminoguanidine compounds rat eye aldose reductase activity vitro respect NADPH Ki mM monoaminoguanidine Ki mM diaminoguanidine administered days dose mg/kg body wt compounds eye lens sorbitol aldose reductase activity normoglycemic alloxan-induced diabetic rats Again diaminoguanidine inhibitor Daily long-term administration mono- diaminoguanidine mg/kg body wt i.p experimental diabetes-induced lens opacity rats diaminoguanidine therapeutic potential diabetic complications